The pervasive culture of instant gratification is a growing concern in Trinidad and Tobago, and it is driving many of the ...

For the uninitiated, the alphabet BBL might draw a blank. Not so for aspiring and practising socialites in our big capital ...

A new study found people with type 2 diabetes who used drugs like Ozempic had a reduced risk of 42 health conditions or issues, but a greater risk of 19 others.

Now, it’s common to hear stories of recovering bulimics, as well as those with anorexia, accessing Ozempic through back channels (in the UK, you can easily obtain the drug from pharmacies by ...

Training aims to ensure no young person is ‘bullied for who they are’ The charity’s chief executive, Laura Mackay, said: “Whether you are preparing for your first job in teaching or have had a long ...

Wegovy and Ozempic have become household names, but how easy are they to get if you don't meet the medical criteria? Sky's Lucy Marley went to find out.

Since the launch of semaglutide weight loss medications, like Ozempic, Pet Poison Helpline has seen multiple cases where a client accidentally administered their diabetic pet the semaglutide weight ...

Semaglutide (known by its brandname Ozempic) has gained widespread attention for its weight loss benefits, but is officially approved for managing type 2 diabetes. While there is currently limited ...

Weight loss drugs like Ozempic and Wegovy cost an average of $1,083 per month if you pay full price or $325 per month after insurance. Find Cheap Health Insurance Quotes in Your Area Weight loss drugs ...

No, it’s not ‘brat’, ‘demure’, or even ‘brain rot’; it’s Ozempic. The drug has become increasingly popular for helping people (including your favourite celebrities) lose weight ...

“Micro-dosing typically involves starting with lower-than-standard doses of medications like Ozempic and other semaglutides, which provide benefits in appetite control and metabolic support ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. This article is part of the Financial Times free schools access programme. Details/registration here ...